CAJ | 학술논문

目的：探讨低分子肝素钠联合酚妥拉明治疗矽肺合并慢性肺源性心脏病的临床效果。方法选择矽肺合并慢性肺源性心脏病患者共46例随机分为治疗组和对照组，两组患者均给予吸氧、抗感染、解痉平喘、祛痰止咳、改善心功能等基础治疗，治疗组患者在上述治疗基础上给予低分子肝素钠和酚妥拉明治疗，治疗后评定两组疗效。结果治疗组总有效率82.61%，对照组总有效率73.91%，治疗组总有效率明显高于对照组，差异有统计学意义(P＜0.05)。结论低分子肝素钠联合酚妥拉明能够显著改善矽肺合并慢性肺源性心脏病患者临床症状和体征，提高治疗效果及患者生活质量，值得推广。
목적：탐토저분자간소납연합분타랍명치료석폐합병만성폐원성심장병적림상효과。방법선택석폐합병만성폐원성심장병환자공46례수궤분위치료조화대조조，량조환자균급여흡양、항감염、해경평천、거담지해、개선심공능등기출치료，치료조환자재상술치료기출상급여저분자간소납화분타랍명치료，치료후평정량조료효。결과치료조총유효솔82.61%，대조조총유효솔73.91%，치료조총유효솔명현고우대조조，차이유통계학의의(P＜0.05)。결론저분자간소납연합분타랍명능구현저개선석폐합병만성폐원성심장병환자림상증상화체정，제고치료효과급환자생활질량，치득추엄。
Objective: the effect of low molecular weight heparin and phentolamine mesylate on patients of coal worker's pneumoconiosis complicated with chronic pulmonary disease in acute Period. Methods: fourty-six coal worker's pneumoconiosis complicated with chronic pulmonary patients were randomly assingned into treatment group and control group ,each group was Tweety-three, low molecular weight heparin and phentolamine mesylate were taken oral y by treatment group, The control group gives the western medicine convention treatment. the therapeutic period is 10 days. Results:Compared with control group, the clinical manifestation was improved evidently in treatment group ,the dif erence was statistical y significant (P<0.05). Conclusion: low molecular weight heparin and phentolamine mesylate is effective in treating on chronic cor pulmonale patients in acute period.